Hermann Luebbert - 28 Jul 2026 Form 4 Insider Report for Biofrontera Inc. (BFRI)

Reporting relationship: CEO & Chairman, Director
Issuer ticker: BFRI
Reported as of: 28 Jul 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 29 Jul 2026, 17:47:43 UTC
Prior SEC filing: 06 Mar 2026
Source filing: View source filing
Reporting owner signature: /s/ Daniel Hakansson, Attorney-in-fact for Hermann Luebbert

Key filing fact

Hermann Luebbert filed Form 4 for Biofrontera Inc. (BFRI) on 29 Jul 2026.

Key facts

This page summarizes Hermann Luebbert's Form 4 filing for Biofrontera Inc. (BFRI).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 29 Jul 2026, 17:47.

Change

Previous filing in this sequence was filed on 06 Mar 2026.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001886492 Primary reporting owner

Luebbert Hermann

Relationship: CEO & Chairman, Director
Address: 660 MAIN STREET, FIRST FLOOR, WOBURN
Signature: /s/ Daniel Hakansson, Attorney-in-fact for Hermann Luebbert
Signature date: 29 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

BFRI transaction

Common Stock

Options Exercise

Transaction value
Shares: +62,500
Change %: +22%
Price
Shares after: 352,711
Date: 28 Jul 2026
Ownership: Direct
Footnotes: F1

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

BFRI transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares: -62,500
Change %: -50%
Price: $0.000000^*
Shares after: 62,500
Date: 28 Jul 2026
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 62,500
Exercise price
Footnotes: F1, F2, F3

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

Each restricted stock unit represents a contingent right to receive one share of BFRI common stock, subject to the company's discretion to settle the restricted stock units, in whole or in part, in cash, as discussed below in footnote 2. The Company elected to convert the restricted stock units into common stock on a one-for-one basis.

Footnote F2

On July 22, 2025, the Reporting Person was granted 125,000 restricted stock units, vesting in two equal yearly installments for the first two years following the grant date, beginning on July 22, 2026. Each vested restricted stock unit will be settled, at the Company's discretion, in shares, cash or a combination of shares and cash within 60 days of the vesting date.

Footnote F3

Restricted stock units with different terms are not included.